Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Vinay Prasad argues the FDA approves too many expensive drugs with minimal patient benefit, attributing this to self-serving incentives and a "death of duty" among healthcare players. He discusses this with EconTalk host Russ Roberts.